However, for 9MFY2023, Delfi reported patmi of US$32.8 million, up 22.1% y-o-y. Renuve was up 15.2% y-o-y to US$412.6 million. Ebitda for the same nine months reached US$52.8 million, up 9.4% y-o-y.
Chocolate maker Delfi has reported a better ebitda for its 9MFY2023 but analysts covering this counter have slightly trimmed their respective target prices as they projectslower growth ahead amid greater macro uncertainty.
For the three months ended Sept 30, Delfi's ebitda dipped by 6.3% y-o-y to US$12.9 million, while revenue was up 12.9% y-o-y to UUS$126.4 million but a mere 0.8% improvement q-o-q. The softer 3QFY2023 was in line with seasonal trends, where marketing and distribution costs were held steady even though demand dipped.
